European Commission says recast consultation confirms need for legislative improvements
This article was originally published in SRA
Executive Summary
The European Commission believes that its consultation on a possible recast of the medical device directives has confirmed the need for legislative changes in the medtech regulatory framework, but it agrees with industry stakeholders that more time is needed to draft formal proposals1-3. Formal proposals are unlikely to emerge this year.